Why Build robots when you can turn a human being into a robot for far less money. Through the technology of mind control and now
robotics we see and I have scene personally how a human being can become a robot over time. Through Torture. It's like in the Star Wars movie when Darth pushes his fingers together and the man starts choking though lack of air. Well in 1996 the NYTimes did a report on how a magnet wire is inbedded into a persons esapahous or other artery and when the wire becomes tighter through magnets the person loses air. I read this article and since this has happened to me 3 times since 1996. Also my hands are bionic and can send codes, that is a gift musically that I have been working on since 15 when I got my first Sony Walkman Professional and was the first at Edward R. Murrow HS to have headphones on. No one new what the fuck it was on my head. Like a CADD computer finding the exact line, so can a bionic body. The future is hear. These are the people you can sue if you should have this problems of the United States Government doing Illegal practices on an Individual American. O but there is a law the Bill Clinton I believed put into effect or maybe it was before. Under the Science Law the United States of America is allowed to do research on its own citizens. All those Americans being killed my mind control Americans. You have to fell bad for James Holmes after all is mind is not he's own. Read Harvard and the Unibomber and find out how he was used in government sponsored mental tests.
DARPA and NIH to fund ‘human body on a chip’ research
July 25th, 2012
Researchers in the Department of Biological Engineering at MIT will receive up to $32 million over the next five years from the Defense Advanced Research Projects Agency (DARPA) and the National Institutes of Health (NIH) to develop a technology platform that will mimic human physiological systems in the laboratory, using an array of integrated, interchangeable engineered human tissue constructs.
A cooperative agreement between MIT and DARPA worth up to $26.3 million will be used to establish a new program titled “Barrier-Immune-Organ: MIcrophysiology, Microenvironment Engineered TIssue Construct Systems” (BIO-MIMETICS) at MIT, in collaboration with researchers at the Charles Stark Draper Laboratory, MatTek Corp. and Zyoxel Ltd. The BIO-MIMETICS proposal was one of two award winners selected as part of the Microphysiological Systems (MPS) program at DARPA, and will be led by MIT professor Linda Griffith in collaboration with MIT professors Steven Tannenbaum, Darrell Irvine, Paula Hammond, Eric Alm and Douglas Lauffenburger. Jeffrey Borenstein and Shankar Sundaram will lead the work at Draper Laboratory, Patrick Hayden will lead the work at MatTek, and David Hughes will lead the work at Zyoxel.
The BIO-MIMETICS program will combine technologies developed at MIT, Draper Laboratory, MatTek and Zyoxel to create a versatile microfluidic platform that can incorporate up to 10 individual engineered human microphysiological organ system modules in an interacting circuit. The modules will be designed to mimic the functions of specific organ systems representing a broad spectrum of human tissues, including the circulatory, endocrine, gastrointestinal, immune, integumentary, musculoskeletal, nervous, reproductive, respiratory and urinary systems. The goal of the program is to create a versatile platform capable of accurately predicting drug and vaccine efficacy, toxicity, and pharmacokinetics in preclinical testing. The BIO-MIMETICS team anticipates that the platform will be suitable for use in regulatory review, amenable to rapid translation to the biopharmaceutical research community, and adaptable for integration of future technologies (such as advances in stem cell technologies and personalized medicine).
A cooperative agreement worth up to $6.25 million from the National Center for Advancing Translational Sciences (NCATS) at NIH will support a complementary research initiative at MIT and Draper Laboratory, in collaboration with professors Alan Wells, Donna Stolz and Raman Venkataramanan at the University of Pittsburgh. The aim of this project is to model cancer metastasis therapies using engineered human tissue constructs, with a goal of adapting this work to the integrated BIO-MIMETICS platform.
Provided by Massachusetts Institute of Technology
